当前位置:
X-MOL 学术
›
Cytom. Part B Clin. Cytom.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Peripheral T-cell lymphoma immunophenotype in a patient with a history of Muromonab-CD3 therapy: A case report and a diagnostic dilemma
Cytometry Part B: Clinical Cytometry ( IF 3.4 ) Pub Date : 2021-05-06 , DOI: 10.1002/cyto.b.22004 Joerg Hoffmann 1 , Andreas Klameth 1 , Martin Russwurm 2 , Andreas Neubauer 1 , Cornelia Brendel 1
中文翻译:
有 Muromonab-CD3 治疗史的患者的外周 T 细胞淋巴瘤免疫表型:病例报告和诊断困境
更新日期:2021-05-06
Cytometry Part B: Clinical Cytometry ( IF 3.4 ) Pub Date : 2021-05-06 , DOI: 10.1002/cyto.b.22004 Joerg Hoffmann 1 , Andreas Klameth 1 , Martin Russwurm 2 , Andreas Neubauer 1 , Cornelia Brendel 1
Affiliation
Peripheral T-cell lymphoma is a rare disease and remains a diagnostic challenge in some cases. Abnormally diminished expression of the pan T-cell markers (i.e. CD3, CD5, CD7, CD2) in flow cytometric immunophenotyping is a hallmark of peripheral T-cell lymphomas. CD3 is often used as a marker for mature T-lymphocytes and loss of cell surface CD3 on T-cells is a typical feature of the angioimmunoblastic T-cell lymphoma (Serke et al., 2000).
中文翻译:
有 Muromonab-CD3 治疗史的患者的外周 T 细胞淋巴瘤免疫表型:病例报告和诊断困境
外周 T 细胞淋巴瘤是一种罕见疾病,在某些情况下仍然是诊断挑战。流式细胞免疫表型分析中泛 T 细胞标志物(即 CD3、CD5、CD7、CD2)的异常减少是外周 T 细胞淋巴瘤的标志。CD3 通常用作成熟 T 淋巴细胞的标志物,T 细胞上细胞表面 CD3 的缺失是血管免疫母细胞 T 细胞淋巴瘤的典型特征(Serke 等, 2000)。